DPP-4 inhibitors

Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

Standard

DPP-4 inhibitors. / Deacon, Carolyn F.

Handbook of incretin therapies in type 2 diabetes. ed. / S Gough. Switzerland : Springer, 2016. p. 45-60.

Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

Harvard

Deacon, CF 2016, DPP-4 inhibitors. in S Gough (ed.), Handbook of incretin therapies in type 2 diabetes. Springer, Switzerland, pp. 45-60. https://doi.org/10.1007/978-3-319-08982-9_4

APA

Deacon, C. F. (2016). DPP-4 inhibitors. In S. Gough (Ed.), Handbook of incretin therapies in type 2 diabetes (pp. 45-60). Switzerland: Springer. https://doi.org/10.1007/978-3-319-08982-9_4

Vancouver

Deacon CF. DPP-4 inhibitors. In Gough S, editor, Handbook of incretin therapies in type 2 diabetes. Switzerland: Springer. 2016. p. 45-60 https://doi.org/10.1007/978-3-319-08982-9_4

Author

Deacon, Carolyn F. / DPP-4 inhibitors. Handbook of incretin therapies in type 2 diabetes. editor / S Gough. Switzerland : Springer, 2016. pp. 45-60

Bibtex

@inbook{3b4767c63bb2494ba25d8eab451cf56e,
title = "DPP-4 inhibitors",
abstract = "Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.",
author = "Deacon, {Carolyn F.}",
year = "2016",
doi = "10.1007/978-3-319-08982-9_4",
language = "English",
isbn = "978-3-319-08981-2",
pages = "45--60",
editor = "S Gough",
booktitle = "Handbook of incretin therapies in type 2 diabetes",
publisher = "Springer",

}

RIS

TY - CHAP

T1 - DPP-4 inhibitors

AU - Deacon, Carolyn F.

PY - 2016

Y1 - 2016

N2 - Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.

AB - Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.

U2 - 10.1007/978-3-319-08982-9_4

DO - 10.1007/978-3-319-08982-9_4

M3 - Book chapter

SN - 978-3-319-08981-2

SP - 45

EP - 60

BT - Handbook of incretin therapies in type 2 diabetes

A2 - Gough, S

PB - Springer

CY - Switzerland

ER -

ID: 162893662